LONG-TERM RESULTS AFTER CARDIAC RESYNCHRONIZATION THERAPY WITH OR WITHOUT SURGICAL REVASCULARIZATION IN PATIENTS WITH ISCHEMIC HEART FAILURE AND LEFT VENTRICLE DYSSYNCHRONY  by Romanov, Alexander et al.
Heart Failure
E653
JACC March 12, 2013
Volume 61, Issue 10
long-Term resulTs afTer cardiac resynchronizaTion Therapy wiTh or wiThouT 
surgical revascularizaTion in paTienTs wiTh ischemic hearT failure and lefT venTricle 
dyssynchrony
Poster Contributions
Poster Sessions, Expo North
Saturday, March 09, 2013, 3:45 p.m.-4:30 p.m.
Session Title: Heart Failure: Cardiac Resynchronization Therapy
Abstract Category: 17. Heart Failure: Therapy
Presentation Number: 1177-304
Authors: Alexander Romanov, Evgeny Pokushalov, Alexander Chernyavskiy, Vitaliy Shabanov, Ilia Stenin, Alexander Karaskov, State Research Institute 
of Circulation Pathology, Novosibirsk, Russian Federation
Background: We have tested the hypothesis whether epicardial cardiac resynchronization therapy (CRT) concomitantly with surgical 
revascularization is superior to CRT and medical therapy in patients with ischemic heart failure, LVEF<35% and LV dyssynchrony, who were eligible to 
coronary artery bypass grafting or medical therapy.
methods: Ninety seven consecutive patients with severe ischemic heart failure were randomly assigned to endocardial CRT implantation plus 
medical therapy (n=48) or epicardial CRT implantation plus CABG (n=49). The primary end point was reduction in left ventricle systolic volume 
(LVESV) by 15% mesured by echocardiography. The major secondary endpoint included the all cause death. The patients were followed up during 24 
months.
results: At 24 months, the mean LVESV was significantly lower in epicardial CRT plus CABG group compared with CRT plus medical therapy group 
(115.4±22.4.% vs. 137.8±19.7%, P=0.002). In epicardial CRT plus CABG group 6 patients (12.2%) died at 2-year follow compared with 11 (22.9%) 
in CRT plus medical therapy group (Log-Rank test, p=0.02). Totally, the number of patients with LVESV reduction by 15% were 37 (86%) in epicardial 
CRT plus CABG group and 25 (67.6%) in CRT plus medical therapy group (p=0.034).
conclusions: In ischemic heart failure patients with LV dyssynchrony, who are eligible to surgical revascularization or medical therapy, epicardial 
implantation of a CRT system concomitantly with CABG is superior to CRT plus medical therapy in terms of cardiac reverse remodeling and is 
associated with low mortality in long-term follow up.
